Literature DB >> 24555632

Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model.

Yue Zhang1, Sarah B White, Jodi R Nicolai, Zhuoli Zhang, Derek L West, Dong-Hyun Kim, A Lee Goodwin, Frank H Miller, Reed A Omary, Andrew C Larson.   

Abstract

PURPOSE: To compare changes on ultrasonographic (US), computed tomographic (CT), and magnetic resonance (MR) images after irreversible electroporation (IRE) ablation of liver and tumor tissues in a rodent hepatoma model.
MATERIALS AND METHODS: Studies received approval from the institutional animal care and use committee. Forty-eight rats were used, and N1-S1 tumors were implanted in 24. Rats were divided into groups and allocated for studies with each modality. Imaging was performed in normal liver tissues and tumors before and after IRE. MR imaging was performed in one group before and after IRE after hepatic vessel ligation. US images were graded to determine echogenicity changes, CT attenuation was measured (in Hounsfield units), and MR imaging signal-to-noise ratio (SNR) was measured before and after IRE. Student t test was used to compare attenuation and SNR measurements before and after IRE (P < .05 indicated a significant difference).
RESULTS: IRE ablation produced greater alterations to echogenicity in normal tissues than in tumors. Attenuation in ablated liver tissues was reduced compared with that in control tissues (P < .001), while small attenuation differences between ablated (42.11 HU ± 2.11) and control (45.14 HU ± 2.64) tumors trended toward significance (P = .052). SNR in ablated normal tissues was significantly altered after IRE (T1-weighted images: pre-IRE, 145.95 ± 24.32; post-IRE, 97.80 ± 18.03; P = .004; T2-weighted images, pre-IRE, 47.37 ± 18.31; post-IRE, 90.88 ± 37.15; P = .023). In tumors, SNR differences before and after IRE were not significant. No post-IRE signal changes were observed after hepatic vessel ligation.
CONCLUSION: IRE induces rapid changes on gray-scale US, unenhanced CT, and MR images. These changes are readily visible and may assist a performing physician to delineate ablation zones from the unablated surrounding parenchyma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24555632      PMCID: PMC4263650          DOI: 10.1148/radiol.14130989

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  42 in total

1.  MR imaging to assess immediate response to irreversible electroporation for targeted ablation of liver tissues: preclinical feasibility studies in a rodent model.

Authors:  Yue Zhang; Yang Guo; Ann B Ragin; Robert J Lewandowski; Guang-Yu Yang; Grace M Nijm; Alan V Sahakian; Reed A Omary; Andrew C Larson
Journal:  Radiology       Date:  2010-08       Impact factor: 11.105

2.  MR monitoring of NaCl-enhanced radiofrequency ablations: observations on low- and high-field-strength MR images with pathologic correlation.

Authors:  Sherif Gamal Nour; S Nahum Goldberg; Frank K Wacker; Shervin Rafie; Simi Paul; Jens O Heidenreich; Mark Rodgers; Fadi W Abdul-Karim; Jeffrey L Duerk; Jonathan S Lewin
Journal:  Radiology       Date:  2010-01-20       Impact factor: 11.105

3.  Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation.

Authors:  Edward W Lee; Christine Chen; Veronica E Prieto; Sarah M Dry; Christopher T Loh; Stephen T Kee
Journal:  Radiology       Date:  2010-05       Impact factor: 11.105

4.  Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma.

Authors:  Yang Guo; Yue Zhang; Rachel Klein; Grace M Nijm; Alan V Sahakian; Reed A Omary; Guang-Yu Yang; Andrew C Larson
Journal:  Cancer Res       Date:  2010-02-02       Impact factor: 12.701

5.  Real-time MR thermometry for monitoring HIFU ablations of the liver.

Authors:  Andrew B Holbrook; Juan M Santos; Elena Kaye; Viola Rieke; Kim Butts Pauly
Journal:  Magn Reson Med       Date:  2010-02       Impact factor: 4.668

6.  Intraprocedural diffusion-weighted PROPELLER MRI to guide percutaneous biopsy needle placement within rabbit VX2 liver tumors.

Authors:  Jie Deng; Sumeet Virmani; Guang-Yu Yang; Richard Tang; Gayle Woloschak; Reed A Omary; Andrew C Larson
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

Review 7.  18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer.

Authors:  Bernd Joachim Krause; Ken Herrmann; Hinrich Wieder; Christian Meyer zum Büschenfelde
Journal:  J Nucl Med       Date:  2009-04-20       Impact factor: 10.057

8.  Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience.

Authors:  Antonio Orlacchio; Gabriele Bazzocchi; Daniela Pastorelli; Francesca Bolacchi; Mario Angelico; Cristiana Almerighi; Salvatore Masala; Giovanni Simonetti
Journal:  Cardiovasc Intervent Radiol       Date:  2008-01-31       Impact factor: 2.740

9.  Histopathologic and immunohistochemical features of tissue adherent to multitined electrodes after RF ablation of liver malignancies can help predict local tumor progression: initial results.

Authors:  Constantinos T Sofocleous; Rodrigo G Nascimento; Lydia M Petrovic; David S Klimstra; Mithat Gonen; Karen T Brown; Lynn A Brody; Anne M Covey; Raymond H Thornton; Yuman Fong; Stephen B Solomon; Lawrence H Schwartz; Ronald P DeMatteo; George I Getrajdman
Journal:  Radiology       Date:  2008-10       Impact factor: 11.105

10.  Central lower attenuating lesion in the ablation zone on immediate follow-up CT after percutaneous radiofrequency ablation for hepatocellular carcinoma: incidence and clinical significance.

Authors:  Yulri Park; Dongil Choi; Hyunchul Rhim; Young-sun Kim; Ji Young Lee; Ilsoo Chang; Hyo K Lim; Cheol Keun Park
Journal:  Eur J Radiol       Date:  2009-05-20       Impact factor: 3.528

View more
  14 in total

1.  Preclinical and clinical evaluation of the liver tumor irreversible electroporation by magnetic resonance imaging.

Authors:  Matteo Figini; Xifu Wang; Tianchu Lyu; Zhanliang Su; Daniele Procissi; Vahid Yaghmai; Andrew C Larson; Zhuoli Zhang
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

2.  Transcatheter intra-arterial perfusion (TRIP)-MRI biomarkers help detect immediate response to irreversible electroporation of rabbit VX2 liver tumor.

Authors:  Matteo Figini; Kang Zhou; Liang Pan; Chong Sun; Bin Wang; Su Hu; Jia Yang; Junjie Shangguan; Aydin Eresen; Yury Velichko; Vahid Yaghmai; Zhuoli Zhang
Journal:  Magn Reson Med       Date:  2019-12-18       Impact factor: 4.668

3.  18F-FDG PET Biomarkers Help Detect Early Metabolic Response to Irreversible Electroporation and Predict Therapeutic Outcomes in a Rat Liver Tumor Model.

Authors:  Xifu Wang; Zhanliang Su; Tianchu Lyu; Matteo Figini; Daniel Procissi; Junjie Shangguan; Chong Sun; Bin Wang; Na Shang; Shanzhi Gu; Quanhong Ma; Andrew C Gordon; Kai Lin; Jian Wang; Robert J Lewandowski; Riad Salem; Vahid Yaghmai; Andrew C Larson; Zhuoli Zhang
Journal:  Radiology       Date:  2017-12-12       Impact factor: 11.105

4.  DWI and DCE-MRI approaches for differentiating reversibly electroporated penumbra from irreversibly electroporated ablation zones in a rabbit liver model.

Authors:  Anna J Shangguan; Chong Sun; Bin Wang; Liang Pan; Quanhong Ma; Su Hu; Jia Yang; Aydin Eresen; Yuri Velichko; Vahid Yaghmai; Zhuoli Zhang
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

5.  Silica-Coated Metal Chelating-Melanin Nanoparticles as a Dual-Modal Contrast Enhancement Imaging and Therapeutic Agent.

Authors:  Soojeong Cho; Wooram Park; Dong-Hyun Kim
Journal:  ACS Appl Mater Interfaces       Date:  2016-12-19       Impact factor: 9.229

6.  Feasibility of a Modified Biopsy Needle for Irreversible Electroporation Ablation and Periprocedural Tissue Sampling.

Authors:  Thomas Wimmer; Govindarajan Srimathveeravalli; Mikhail Silk; Sebastien Monette; Narendra Gutta; Majid Maybody; Joseph P Erinjery; Jonathan A Coleman; Stephen B Solomon; Constantinos T Sofocleous
Journal:  Technol Cancer Res Treat       Date:  2015-10-06

7.  Careful treatment planning enables safe ablation of liver tumors adjacent to major blood vessels by percutaneous irreversible electroporation (IRE).

Authors:  Bor Kos; Peter Voigt; Damijan Miklavcic; Michael Moche
Journal:  Radiol Oncol       Date:  2015-08-21       Impact factor: 2.991

Review 8.  Irreversible electroporation in primary and metastatic hepatic malignancies: A review.

Authors:  Tianchu Lyu; Xifu Wang; Zhanliang Su; Junjie Shangguan; Chong Sun; Matteo Figini; Jian Wang; Vahid Yaghmai; Andrew C Larson; Zhuoli Zhang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

9.  Comparison of ablation defect on MR imaging with computer simulation estimated treatment zone following irreversible electroporation of patient prostate.

Authors:  Govindarajan Srimathveeravalli; Francois Cornelis; Joseph Mashni; Haruyuki Takaki; Jeremy C Durack; Stephen B Solomon; Jonathan A Coleman
Journal:  Springerplus       Date:  2016-02-29

10.  Magnetic Resonance Imaging Findings After Percutaneous Irreversible Electroporation of Liver Metastases: A Systematic Longitudinal Study.

Authors:  Alexandra Barabasch; Martina Distelmaier; Philipp Heil; Nils Andreas Krämer; Christiane K Kuhl; Philipp Bruners
Journal:  Invest Radiol       Date:  2017-01       Impact factor: 6.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.